Head-to-head · WeighScore
Enhance MD vs KERNX Health
The verdict
Enhance MD takes it — 84.8/100 to 71.8/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Enhance MD | KERNX Health |
|---|---|---|
| WeighScore | 84.8/100 | 71.8/100 |
| Grade | B | C |
| Site position | #5 | #98 |
| Semaglutide | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay | $129/mo (compounded, plus a one-time consultation fee) |
| Tirzepatide | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay | $229/mo (compounded, plus a one-time consultation fee) |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #5 · B
Strengths
- Transparent tiered pricing across sema, tirz, microdose, and combo
- Dose-flat — the price does not step up as you titrate
- Six-month lab testing plus provider-led care
- NAD+ longevity adjacency available
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- No oral or sublingual route
- States served are not published
- Higher entry price than the cheapest compounded programs
Site position #98 · C
Strengths
- Prescribing clinicians are listed by name and credential rather than described as an anonymous "licensed provider network"
- A provider approves treatment before any charge is processed, and the site states plainly when it is not the right fit
- Monthly provider check-ins and a care team reachable seven days a week are included in the plan rather than sold as an upgrade
- The dose ladder is published for both molecules, so a dose escalation has a known price attached before it happens
Where it loses points
- The dispensing pharmacy is disclosed only in post-purchase paperwork, so no 503A or 503B status can be checked before you commit
- Lab work is not part of the program: it is recommended case by case, billed separately, and may be sent to your own provider
- Explicitly no health coaching or behavioral support — clinical oversight only
- Injectable compounded medication only, with no oral route and no FDA-approved brand pathway
- Cash-pay only, so nothing routes through insurance and no claim can be submitted for you
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.